Back to Trades
Bendheim Daniel M
President and CEODirectorCIK 0001601576
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 4
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Bendheim Daniel M, President and CEO, Director, has filed 4 SEC reports (2025–2026), all concentrated in PHIBRO ANIMAL HEALTH CORP (PAHC), totaling $17.8K in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| Aug 10 | PAHC PHIBRO ANIMAL HEALTH CORP | Bendheim Daniel M | President and CEO, Director | Grant | $0 |
| Aug 6 | PAHC PHIBRO ANIMAL HEALTH CORP | Bendheim Daniel M | President and CEO, Director | Other | $17.8K |
| Jul 2 | PAHC PHIBRO ANIMAL HEALTH CORP | Bendheim Daniel M | President and CEO, Director | Award | $0 |
| Aug 19 | PAHC PHIBRO ANIMAL HEALTH CORP | Bendheim Daniel M | Exec. VP, Corporate Strategy, Director | Grant | $0 |
4 filings